Hisamitsu Pharmaceutical Co Inc 最近的每股盈餘為 $, $ 的預期。
Hisamitsu Pharmaceutical Co Inc HTSUY 上一季度的收入表現如何?
Hisamitsu Pharmaceutical Co Inc 上一季度的收入為 $
Hisamitsu Pharmaceutical Co Inc 的收入預期是多少?
根據 2 位華爾街分析師的預測,Hisamitsu Pharmaceutical Co Inc 的收入預期範圍從 $39.9B 到 $37.24B
Hisamitsu Pharmaceutical Co Inc 的盈利品質評分是多少?
Hisamitsu Pharmaceutical Co Inc 的盈利品質評分為 /。該評分基於盈利能力、增長、現金生成與資本分配以及槓桿四個維度。
Hisamitsu Pharmaceutical Co Inc 何時發布財報?
Hisamitsu Pharmaceutical Co Inc 的下一份財報預計在 2026-04-07 發布
Hisamitsu Pharmaceutical Co Inc 的預期收益是多少?
根據華爾街分析師的預測,Hisamitsu Pharmaceutical Co Inc 的預期收益為 $
Hisamitsu Pharmaceutical Co Inc 是否超出收益預期?
Hisamitsu Pharmaceutical Co Inc 最近的收益為 $, 預期。
關鍵數據
前收市價
$6.65
開盤價
$6.65
當日範圍
$6.65 - $6.65
52週區間
$6 - $6.79
交易量
30
平均成交量
4
股息收益率
--
每股盈餘 (TTM)
--
市值
$499.8M
什麼是 HISAMITSU PHARMACEUTICAL CO INC?
Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 2,799 full-time employees. The firm is engaged in the manufacture, sale and supply of pharmaceuticals and related products, and the operation of over-the-counter drug (OTC) business. The company is also engaged in the manufacture and sale of drugs in the United States, Brazil, Vietnam, and Indonesia, the development work in Europe, the drug marketing and sales in China and Hong Kong. The company is also engaged in the urban cable television broadcasting business, Internet connection service business, non-life insurance agency business, advertising agency business and the purchase, manufacture and sale of packing materials.